This inventor holds 15 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Allergan, Inc.. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Irvine, CA (US) (2012 - 2015)
- Westminster, CA (US) (2015 - 2022)
Company Filing History:
Years Active: 2012-2025
Title: The Innovative Contributions of Wajdie M Ahmad
Introduction
Wajdie M Ahmad, a prominent inventor based in Westminster, CA, has made significant strides in the field of neurotoxin research and development. With a remarkable portfolio of 15 patents, Ahmad stands out as a key contributor to advancements in therapeutic and cosmetic applications of botulinum neurotoxin.
Latest Patents
Among Wajdie M Ahmad's latest innovations is the patented "Process and system for obtaining botulinum neurotoxin - Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use." This cutting-edge process emphasizes efficiency and safety, utilizing animal protein-free technology to produce high-quality neurotoxin relevant for various applications.
Career Highlights
Ahmad's career is marked by his affiliation with Allergan, Inc., a leading company in the biotechnology and pharmaceutical sectors. His work has significantly impacted the development of products that leverage botulinum neurotoxin for medical and aesthetic purposes, fostering innovations that have reshaped approaches in these industries.
Collaborations
Throughout his journey, Wajdie M Ahmad has collaborated with notable colleagues such as Jennifer L Ton and Hemant A Patel. These partnerships have not only enriched his work but also expanded the breadth of research and development in their shared field of expertise.
Conclusion
Wajdie M Ahmad exemplifies the spirit of innovation within the biotechnology industry. His contributions, particularly in the realm of neurotoxin processes, highlight the ongoing advancement of medical and cosmetic technologies. With continued dedication, Ahmad is poised to further influence the landscape of therapeutic innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
